Janice Chen is the co-founder and CTO of Mammoth Biosciences, a biotechnology company harnessing a revolutionary gene-editing tool called CRISPR for rapid and affordable disease detection. Based in South San Francisco, Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Janice received her Ph.D. from the lab of Professor Jennifer Doudna at University of California, Berkeley. She has authored multiple publications and patents related to CRISPR mechanism and technologies, and co-invented the programmable CRISPR-based detection technology called DETECTR. Janice was selected as a 2019 Forbes 30 Under 30 in Healthcare, and delivered a TEDx talk on the potential for CRISPR to democratize diagnostics.
Co-founder and CTO